These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 27836505

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial.
    Kourtis AP, Wiener J, Hurst S, Nelson JAE, Cottrell ML, Corbett A, Chinula L, Msika A, Haddad LB, Tang JH.
    J Acquir Immune Defic Syndr; 2019 Jun 01; 81(2):163-165. PubMed ID: 31095006
    [Abstract] [Full Text] [Related]

  • 3. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
    Chinula L, Nelson JAE, Wiener J, Tang JH, Hurst S, Tegha G, Msika A, Ellington S, Hosseinipour MC, Mataya R, Haddad LB, Kourtis AP.
    Contraception; 2018 Sep 01; 98(3):193-198. PubMed ID: 29746813
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE, Tharp GK, Patel NB, Zhao C, Payne TL, Dietz Ostergaard S, Butler K, Ellis S, Johnson RL, Kersh EN, McNicholl JM, Vishwanathan SA.
    Am J Reprod Immunol; 2018 Oct 01; 80(4):e13029. PubMed ID: 30076667
    [Abstract] [Full Text] [Related]

  • 8. Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception.
    Heffron R, Mugo N, Were E, Kiarie J, Bukusi EA, Mujugira A, Frenkel LM, Donnell D, Ronald A, Celum C, Baeten JM, Partners PrEP Study Team.
    AIDS; 2014 Nov 28; 28(18):2771-6. PubMed ID: 25493602
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K, Nyange P, Martin HL, Ndinya-Achola J, Bwayo JJ, Kreiss JK.
    Lancet; 1997 Sep 27; 350(9082):922-7. PubMed ID: 9314871
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data.
    Patel RC, Baeten JM, Heffron R, Hong T, Davis NL, Nanda K, Coombs RW, Lingappa JR, Bukusi EA, Hurst S, Thomas KK, Kourtis AP, Mugo N, Partners in Prevention HSVHIV Transmission Study and Partners PrEP Study Teams.
    J Acquir Immune Defic Syndr; 2017 May 01; 75(1):91-96. PubMed ID: 28399558
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Progestin-only contraception: injectables and implants.
    Jacobstein R, Polis CB.
    Best Pract Res Clin Obstet Gynaecol; 2014 Aug 01; 28(6):795-806. PubMed ID: 24996766
    [Abstract] [Full Text] [Related]

  • 17. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
    Byrne EH, Anahtar MN, Cohen KE, Moodley A, Padavattan N, Ismail N, Bowman BA, Olson GS, Mabhula A, Leslie A, Ndung'u T, Walker BD, Ghebremichael MS, Dong KL, Kwon DS.
    Lancet Infect Dis; 2016 Apr 01; 16(4):441-8. PubMed ID: 26723758
    [Abstract] [Full Text] [Related]

  • 18. Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.
    Buckner LR, Drobnis EZ, Augustine MS, Rogers LK, Akers J, Mott PD, Hope TJ, Quayle AJ, Schust DJ.
    PLoS One; 2019 Apr 01; 14(5):e0214152. PubMed ID: 31095572
    [Abstract] [Full Text] [Related]

  • 19. Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.
    Guthrie BL, Introini A, Roxby AC, Choi RY, Bosire R, Lohman-Payne B, Hirbod T, Farquhar C, Broliden K.
    J Acquir Immune Defic Syndr; 2015 May 01; 69(1):1-10. PubMed ID: 25622059
    [Abstract] [Full Text] [Related]

  • 20. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje ZM, Bunge K, Ramjee G, Nair G, Palanee-Phillips T, Selepe P, van der Straten A, Parikh UM, Gomez K, Piper JM, Watts DH, Marrazzo JM, VOICE Study Team.
    Lancet HIV; 2015 Jul 01; 2(7):e279-87. PubMed ID: 26155597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.